Delaqua Pharmaceuticals
UEI: K8KTE53NVVL9
• CAGE: 8ELG3
Overview
Awardee Type
Parent
Name
Delaqua Pharmaceuticals
Headquarters
Chapel Hill, NC
United States
United States
Most Recent Award
Sept. 1, 2024
Calculating
Federal grant recipient
DELAQUA PHARMACEUTICALS, INC
dba DELAQUA PHARMACEUTICALS INC
(UEI K8KTE53NVVL9, CAGE 8ELG3)
is headquartered in Chapel Hill NC.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in March 2018 and
federally registered in
October 2019.
Federal Award Analysis
Delaqua Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
DELAQUA PHARMACEUTICALS, INC
DBA
DELAQUA PHARMACEUTICALS INC
UEI
K8KTE53NVVL9
CAGE Code
8ELG3
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 26, 2018
Initial Registration
Oct. 4, 2019
Last Registration
Aug. 20, 2025
Registration Activation
Aug. 20, 2025
Registration Expiration
Aug. 18, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No